Centogene AG - the Rare Disease Company
- Centogene AG - the Rare Disease Company
- Am Strande 7, CENTOGENE New Headquarter
- Rostock, Mecklenburg-Vorpommern, Germany 18055
- Phone: +49 381 80113 400
Fax: +49 381 203652209
Email: Customer.Support@centogene.com - Website: https://www.centogene.com/company/contact.html
GTR Lab ID: 279559, Last updated:2023-10-03
Annual Review past due read more
Personnel
- Director: Johannes Numrich, PhD, Lab Director
Email: johannes.numrich@centogene.com - Elizabeth Couchon, MS, CGC, Genetic Counselor
- Department of Customer Support, Genetic Counselor
Phone: +49 (0) 381 - 80113 416
Email: Customer.Support@centogene.com - Peter Bauer, MD, Medical Director
Phone: +49 381 203 652 0
Fax: +49 381 203 652 19
Email: peter.bauer@centogene.com - Aida Bertoli-Avella, Genetic Counselor
Phone: +49 381 203 652 121
Fax: +49 381 203 652 19
Email: aida.bertoli-avella@centogene.com
Conditions and tests
List of services
- Clinical Testing/Confirmation of Mutations Identified Previously
- Custom Deletion/Duplication Testing
- Prenatal testing
- Custom Sequence Analysis
- Carrier testing
- Genetic counseling
- Maternal cell contamination study (MCC)
- Mutation Confirmation
- Uniparental Disomy (UPD) Testing
- Whole Exome Sequencing
- Whole Genome Sequencing
List of certifications/licenses
Certifications
- CLIAHelpCertification number assigned by the Clinical Laboratory Improvement Amendments (CLIA) program to the laboratory director. Minimal field for US labs offering clinical tests. Optional field for international labs or US labs performing research tests. If pending renewal or record has not been updated, the expiration date may be in the past., Number: 99D2049715, Expiration date: 2025-04-02
- CAP, Number: 8005167, Expiration date: 2024-08-06
- ISO15189:2012 (CAP # 8005167), Number: ISO15189:2012 (CAP # 8005167), Expiration date: 2024-08-06
Participation in external programs
Data exchange Programs
- Mutation-specific Databases
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.